Free Trial

Ascendis Pharma A/S (ASND) SEC Filings & 10K Form

Ascendis Pharma A/S logo
$128.64
+2.87 (+2.28%)
(As of 02:08 PM ET)

Recent Ascendis Pharma A/S SEC Filings

DateFilerForm TypeView
09/30/2024
7:35 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/27/2024
3:59 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/18/2024
4:20 PM
Ascendis Pharma A/S (Filer)
Form 424B5
09/18/2024
3:01 PM
Ascendis Pharma A/S (Filer)
Form F-3ASR
09/16/2024
6:28 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/16/2024
6:32 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/11/2024
3:01 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/03/2024
4:10 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/03/2024
4:11 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/03/2024
4:14 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/12/2024
6:05 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/28/2024
5:07 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/31/2024
3:26 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/29/2024
3:08 PM
Ascendis Pharma A/S (Filer)
Form SD
Specialized Disclosure Report  
05/14/2024
1:37 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/24/2024
8:16 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/07/2024
10:31 AM
Ascendis Pharma A/S (Subject)
Bodenhoff Mads (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2024
8:39 PM
Ascendis Pharma A/S (Subject)
Fairey William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2024
8:47 AM
Ascendis Pharma A/S (Subject)
Cha Albert (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2024
7:04 AM
Ascendis Pharma A/S (Subject)
SPROGOE KENNETT (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2024
7:14 AM
Ascendis Pharma A/S (Subject)
Morrison Lisa (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2024
6:52 AM
Ascendis Pharma A/S (Subject)
MIKKELSEN JAN MOLLER (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2024
6:37 AM
Ascendis Pharma A/S (Subject)
JENSEN FLEMMING STEEN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
1:54 PM
Ascendis Pharma A/S (Subject)
PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
2:07 PM
Ascendis Pharma A/S (Subject)
JENSEN MICHAEL WOLFF (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
2:17 PM
Ascendis Pharma A/S (Subject)
RASMUSSEN PETER (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
1:36 PM
Ascendis Pharma A/S (Subject)
SMITH SCOTT THOMAS (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
1:24 PM
Ascendis Pharma A/S (Subject)
SINGEL STINA (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
10:00 AM
Ascendis Pharma A/S (Subject)
HOLTUG LARS (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/29/2024
4:13 PM
Ascendis Pharma A/S (Subject)
Morrison Lisa (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/29/2024
3:21 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/28/2024
5:17 PM
Ascendis Pharma A/S (Subject)
MIKKELSEN JAN MOLLER (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2024
4:45 PM
Ascendis Pharma A/S (Subject)
PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2024
2:17 PM
Ascendis Pharma A/S (Subject)
JENSEN MICHAEL WOLFF (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/16/2024
4:14 PM
Ascendis Pharma A/S (Subject)
Volck Birgitte (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/16/2024
4:15 PM
Ascendis Pharma A/S (Subject)
JENSEN FLEMMING STEEN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/16/2024
4:16 PM
Ascendis Pharma A/S (Subject)
SMITH SCOTT THOMAS (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2024
10:40 AM
Ascendis Pharma A/S (Subject)
JENSEN MICHAEL WOLFF (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2024
8:17 AM
Ascendis Pharma A/S (Subject)
Avoro Capital Advisors LLC (Filed by)
Form SC 13G/A
02/13/2024
10:57 AM
Ascendis Pharma A/S (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G/A
02/12/2024
5:12 AM
Artisan Partners Limited Partnership (Filed by)
Ascendis Pharma A/S (Subject)
Form SC 13G/A
The Final Frontier (Ad)

And a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt to discredit it, tar and feather it, and convince you not to watch it. That’s because it tells the shocking truth about the current AI mania… and why investors in big tech companies like Nvidia, Meta, Alphabet, and Microsoft could be in for a whole world of pain.

02/09/2024
1:17 PM
Ascendis Pharma A/S (Subject)
MIKKELSEN JAN MOLLER (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/09/2024
7:35 AM
Ascendis Pharma A/S (Subject)
FMR LLC (Filed by)
Form SC 13G/A
02/07/2024
3:15 PM
Ascendis Pharma A/S (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
02/02/2024
12:18 PM
Ascendis Pharma A/S (Subject)
WESTFIELD CAPITAL MANAGEMENT CO LP (Filed by)
Form SC 13G/A
01/29/2024
7:36 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2024
5:05 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2024
5:08 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/02/2024
5:08 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/20/2023
7:30 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/11/2023
7:32 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/07/2023
1:53 PM
Ascendis Pharma A/S (Subject)
Volck Birgitte (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/05/2023
3:20 PM
Ascendis Pharma A/S (Subject)
RASMUSSEN PETER (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/29/2023
5:04 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/15/2023
7:30 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ASND) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners